Search

We’re here for as long as you need us. Learn about the counseling and support services we offer our patients and survivors.

… At Memorial Sloan Kettering, we know that even after you’ve finished your cancer treatments, you may still need our help. We’re committed to supporting you in every way we can — physically, emotionally, spiritually, and otherwise — for as long as you need us. We’ve built a program designed for cancer

Soybeans are widely consumed as food. Isoflavones present in soy are marketed as dietary supplements to treat hot flashes, high cholesterol, and for cancer prevention.

… Common Name Soybean, Soya, Tofu, Miso, Tempeh What is it? Soybeans are rich in protein and other important nutrients. Soy is found in foods such as tofu, miso, soy sauce, and tempeh. It contains large amounts of substances known as isoflavones that help treat hot flashes and lower high cholesterol. Isoflavones

Memorial Sloan Kettering’s 37th annual academic Convocation and the fifth Louis V. Gerstner Graduate School of Biomedical Sciences Commencement shared the spotlight on May 19.

… Tuesday, July 5, 2016 An afternoon ceremony on May 19 celebrated MSK’s 37th annual Convocation and the fifth Louis V. Gerstner Graduate School of Biomedical Sciences Commencement. Presided over by MSK President and CEO Craig Thompson , it recognized students who conducted their doctoral dissertation

… Philanthropy is essential to advancing the mission of the CER. Additional support will provide MSK scientists and doctors with the resources they need to better understand epigenetic processes and develop new therapeutic strategies. The CER is grateful to the following donors whose significant gifts

Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University and Weill Cornell Medicine announced today that they have established a new drug discovery company called Bridge Medicines. Launched in partnership with Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management, Bridge Medicines is a groundbreaking initiative that completes a seamless, fully funded and professionally staffed path from concept to drug candidate to efficiently and rapidly develop innovative therapeutics for treating human diseases.

… Monday, October 31, 2016 Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine announced today that they have established a new drug discovery company called Bridge Medicines. Launched in partnership with Takeda Pharmaceutical Company Ltd. and healthcare investment

… Job Title Postdoctoral Fellow Senior Scientist, 2021–present AbbVie North Chicago, Illinois PhD, Columbia University, 2018 with Prof. Tomislav Rovis Department of Chemistry BS, CUNY Brooklyn College, 2013 Degree PhD Start Year 2018 End Year 2021 Email [email protected] Lab Fax 646-422-0416 (shared) Lab

… SK 440 Description SK-MM-1 is a multiple myeloma cell line that grows in suspension culture. These cells display plasmacytoid morphology and have a doubling time of approximately 32 hours. SK-MM-1 cells do not express the Epstein-Barr virus nuclear antigen. These cells express the pan-B-cell marker B1

… Job Title Research Fellow Education PhD, Tokyo Medical and Dental University, Tokyo, Japan

Learn more about physician-led translational and clinical research teams within Memorial Hospital.

… Within Memorial Hospital, there are many physician-led translational and clinical research teams. Our investigators conduct research ranging from validating artificial intelligence tools for dermatology applications to analyzing mechanistic underpinnings of brain metastasis to using behavioral science

Learn how our donor community is supporting MSK research and education.

… Thursday, April 1, 2021 Every day, your dollars are accelerating today’s most daring discoveries straight into lifesaving care. Read more to learn about your impact. The Society of Memorial Sloan Kettering Winter Lunch On February 3, The Society of MSK hosted its eighth annual Winter Lunch to support